Literature DB >> 21964400

Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study.

Alan G Nyitray1, Roberto J Carvalho da Silva, Maria Luiza Baggio, Dan'elle Smith, Martha Abrahamsen, Mary Papenfuss, Hui-Yi Lin, Manuel Quiterio, Jorge Salmerón, Eduardo Lazcano-Ponce, Luisa L Villa, Anna R Giuliano.   

Abstract

BACKGROUND: Although there are limited numbers of incidence and persistence estimates for anal human papillomavirus (HPV) in women and in men who have sex with men (MSM), there are no such reports for men who have sex with women (MSW).
METHODS: Genotyping was performed on anal samples from men, aged 18-70, from São Paulo, Brazil; Cuernavaca, Mexico; and Tampa, Florida, who provided specimens at enrollment and the 6-month visit of a 4-year prospective study. Eligibility included no history of genital warts or human immunodeficiency virus. A total of 954 MSW and 156 MSM provided evaluable specimens at both visits. Persistence was defined as type-specific infection at each visit.
RESULTS: Incident anal infection was common among both MSM and MSW but generally higher for MSM for HPV groups and specific genotypes. A total of 5.1% of MSM and 0.0% of MSW had a persistent HPV-16 infection at the 6-month visit. Cigarette smoking among MSM and age among MSW were associated with persistent infection with any HPV genotype.
CONCLUSIONS: Although anal HPV infection is commonly acquired by both MSW and MSM, incident events and persistence occurred more often among MSM. Cigarette smoking is a modifiable risk factor that may contribute to HPV persistence among MSM.

Entities:  

Mesh:

Year:  2011        PMID: 21964400      PMCID: PMC3203231          DOI: 10.1093/infdis/jir637

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Causal diagrams for epidemiologic research.

Authors:  S Greenland; J Pearl; J M Robins
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

3.  Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999.

Authors:  Rosemary D Cress; Elizabeth A Holly
Journal:  Prev Med       Date:  2003-05       Impact factor: 4.018

4.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.

Authors:  J M Palefsky; E A Holly; M L Ralston; N Jay; J M Berry; T M Darragh
Journal:  AIDS       Date:  1998-03-26       Impact factor: 4.177

6.  The carcinogenicity of human papillomavirus types reflects viral evolution.

Authors:  Mark Schiffman; Rolando Herrero; Rob Desalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; Maria C Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John Schussler; Philip E Castle; Robert D Burk
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

7.  Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; S Shiboski; A Moss
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-06

8.  Smoking-related DNA adducts in anal epithelium.

Authors:  David H Phillips; Alan Hewer; John H Scholefield; Paul Skinner
Journal:  Mutat Res       Date:  2004-06-13       Impact factor: 2.433

Review 9.  The epidemiology of cervical cancer.

Authors:  Eduardo L Franco; Nicolas F Schlecht; Debbie Saslow
Journal:  Cancer J       Date:  2003 Sep-Oct       Impact factor: 3.360

10.  Effect of HIV infection on the natural history of anal human papillomavirus infection.

Authors:  C W Critchlow; S E Hawes; J M Kuypers; G M Goldbaum; K K Holmes; C M Surawicz; N B Kiviat
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

View more
  46 in total

Review 1.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

2.  Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers.

Authors:  Megan A Clarke; Nicolas Wentzensen
Journal:  Cancer Cytopathol       Date:  2018-05-24       Impact factor: 5.284

3.  The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Authors:  Alan G Nyitray; Fen Peng; Rena S Day; Roberto J Carvalho Da Silva; Maria Luiza Baggio; Jorge Salmerón; Manuel Quiterio; Martha Abrahamsen; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

4.  Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study.

Authors:  Shitaldas J Pamnani; Alan G Nyitray; Martha Abrahamsen; Dana E Rollison; Luisa L Villa; Eduardo Lazcano-Ponce; Yangxin Huang; Amy Borenstein; Anna R Giuliano
Journal:  J Infect Dis       Date:  2016-08-03       Impact factor: 5.226

5.  Radiochemotherapy in Anal Cancer: cCR, clinical outcomes and quality of life using two different treatment schedules.

Authors:  Sara Di Santo; Marianna Trignani; Matteo Neri; Angelo Milano; Paolo Innocenti; Maria Taraborrelli; Antonietta Augurio; Annamaria Vinciguerra; Monica Di Tommaso; Lucia Anna Ursini; Angelo Di Pilla; Marta Di Nicola; Domenico Genovesi
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-22

6.  Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Authors:  Carmen Hidalgo-Tenorio; Jessica Ramírez-Taboada; Concepción Gil-Anguita; Javier Esquivias; Mohamed Omar-Mohamed-Balgahata; Antonio SamPedro; Miguel Lopez-Ruz; Juan Pasquau
Journal:  AIDS Res Ther       Date:  2017-07-18       Impact factor: 2.250

Review 7.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

Review 8.  HPV and anal cancer in HIV-infected individuals: a review.

Authors:  Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

9.  Natural history of anal vs oral HPV infection in HIV-infected men and women.

Authors:  Daniel C Beachler; Gypsyamber D'Souza; Elizabeth A Sugar; Wiehong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2013-04-17       Impact factor: 5.226

Review 10.  Anal cancer: are we making progress?

Authors:  Ajay Aggarwal; Simon Duke; Rob Glynne-Jones
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.